Mild, localized rashes that resolve within a few days typically do not require discontinuation
In clinical studies, the average weight loss was 15% and 20% with 77% of patients seeing sustained results for 2 years* *In a 68- and 72-week clinical trial studying Semaglutide in patients without diabetes and with BMI 30, or BMI 27 with a weight-related condition, the average weight loss was 15% and 20%, when paired with diet and exercise changes (compared to 2.4% and 3.1%, respectively, with diet and exercise alone)
Each approach offers distinct advantages depending on researcher needs, urgency requirements, and quality expectations
LegitScript is the industry gold standard for online healthcare providers, and its absence means the clinic cannot advertise on Google or major platforms
The Patent Context: While GLP-1s like Ozempic and Wegovy generally have patent protection in the U.S
Rather than using exogenous recombinant GH, we can stimulate natural GH secretion with peptides like sermorelin, CJC-1295/ipamorelin, or tesamorelin